Pharmaterials Ltd is a science driven contract research organization specializing in the optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trials materials.
We have a wealth of experience in the development of low solubility drug substances and have taken a great many such formulations to the clinic.
We provide a complete formulation service for inhaled drug delivery using dry powder inhaler (DPI) and pressurized metered dose inhaler(pMDI) systems.
Using (optionally) high-throughput screening technologies in both physical form generation and formulation design,we assist biotechnology and pharmaceutical companies to rapidly and successfully progress their problematic lead compounds into the clinical phases of development. With partnerships that span the globe, Pharmaterials works with arange of organisations, including start-up, mid-size and multinational companies.
We can assist with, or fully manage, projects as needed, from bespoke salt selection and polymorphism screening services through to full formulation screening and development programs.
The Pii / Pharmaterials Corporate Vision
To become the benchmark in pharmaceutical product development and commercial manufacturing outsourcing.
Pharmaterials Customer Values
We have clear customer focus defined in a few simple values
- Communication– we will agree a schedule of communication and stick to it. You will receive good news, and if necessary less good news, in a timely fashion.
- You will always be aware of the status of your project.
- Added Value – throughout our activities we work to the spirit of “We don’t just measure, we understand”. We will bring experience and understand to your work and will not just present you with data (unless that is your declared wish!), but rather with knowledge derived from data. This value runs through all aspects of our work.
- Quality – we pride ourselves in producing high quality work to tight timelines.
Pharmaterials was founded in January 2000 by Professor Graham Buckton as a spin-out company from the London School of Pharmacy, UK. Since inception, the company grew through an organic business model and in 2005, due to a period of sustained business growth moved to state-of-the-art laboratories and offices in Reading, UK. The company offers services spanning many aspects of drug development with the commitment to exceptional service reflected in our high rate of return business.
In January 2008 PII acquired Pharmaterials providing an enhanced service for our customers, with full GMP manufacturing and stability testing.
PharmaterialsLtd is a registered company in England with company number 3973760 and registered address Unit B, 5 Boulton Road, Reading, RG2 0NH, UK.